3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
51
Carcinoma, Non-Small-Cell Lung
50
Carcinoma, Renal Cell
38
Neoplasm Metastasis
20
Carcinoma, Hepatocellular
20
Lung Neoplasms
19
Squamous Cell Carcinoma of Head and Neck
17
Neoplasms
17
Stomach Neoplasms
15
Colorectal Neoplasms
15
Carcinoma, Transitional Cell
14
Adenocarcinoma Of Esophagus
12
Prostatic Neoplasms
10
Hodgkin Disease
10
Brain Neoplasms
10
Urinary Bladder Neoplasms
8
Pancreatic Neoplasms
8
Ovarian Neoplasms
8
Multiple Myeloma
8
Triple Negative Breast Neoplasms
7
Rectal Neoplasms
7
Esophageal Neoplasms
7
Clear-cell metastatic renal cell carcinoma
7
Breast Neoplasms
7
Recurrence
6
Colonic Neoplasms
6
Carcinoma, Basal Cell
6
Carcinoma
6
Uveal Melanoma
5
Uterine Cervical Neoplasms
5
Interventions
Gemcitabine
10
Mitomycin
7
Docetaxel
5
erdafitinib
4
durvalumab
4
BCG Vaccine
4
dodecyl maltoside
3
Cystoscopy
3
ALT-803
2
viscum album peptide
1
tremelimumab
1
pirarubicin
1
monalizumab
1
hydroxycamptothecinum
1
disitamab vedotin
1
chondroitin sulfate, sodium hyaluronate drug combination
1
Watchful Waiting
1
Transurethral Resection of Bladder
1
Patient Discharge
1
Mitozytrex
1
Magnetic Resonance Spectroscopy
1
Injections
1
Hyaluronic Acid
1
House Calls
1
Home Care Services
1
Epirubicin
1
Drainage
1
Clinical Trials, Phase II as Topic
1
Clinical Trials, Phase I as Topic
1
Chondroitin Sulfates
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Non-Muscle Invasive Bladder Neoplasms
×
Nivolumab
×
90 days
×
Clear all
No trials found.